Navigating the Future of AI in Pharma: AI agents will need limitations

Audio

Description

AI has revolutionized drug discovery by enabling scientists to process vast amounts of historical data, thus accelerating the identification of disease targets and molecule development. AI helps avoid past mistakes and improves the quality of research, making it an indispensable tool in the lab. MSD's approach to AI involves a blend of internal talent and strategic partnerships. By combining computational and web science expertise, MSD ensures that both technological and scientific endpoints are effectively addressed, says Matt Studney, SVP of Research Labs at MSD. Topics addressed: Internal vs. External AI Development at MSD Global Data Management Challenges Generative AI's Impact on Drug Discovery Confidential AI Systems and Documentation Challenges in AI Integration Workforce Upskilling and Cultural Change Future Breakthroughs and Concerns Synthetic Data and Drug Repurposing www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Youtube: https://youtu.be/pgCz-tgHaL0

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Faces of Digital Health

This episode hasn't been transcribed yet

Other recent transcribed episodes

3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE

13:00H | 21 DIC 2025 | Fin de Semana

12:00H | 21 DIC 2025 | Fin de Semana

10:00H | 21 DIC 2025 | Fin de Semana

13:00H | 20 DIC 2025 | Fin de Semana

12:00H | 20 DIC 2025 | Fin de Semana

Sign in to Audioscrape

Share this moment